Our Recommendations
- Notes de la Consultationsur le contrôle de l’utilisationen situation d’urgence d’interventions thérapeutiques non homologuées pour le traitementde la maladie à virus Ebola (MVE) (2018)
- Notes for the record: Consultation on Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) for Ebola Virus Disease (EVD) (2018)
New Publications
Filter
36
Featured
Recommendations
2
New Publications
26
Language
Document type
No document type
36
Countries / Regions
Congo, Democratic Republic of
10
Guinea
6
Liberia
5
Uganda
3
Sierra Leone
2
Rwanda
2
West and Central Africa
2
South Sudan
2
Nigeria
1
Senegal
1
Authors & Publishers
Publication Years
Category
Humanitarian Crisis
2
Vaccine-preventable Diseases
1
Hemorrhagic Fever
1
Toolboxes
Research
36
Treatment Guidelines
6
Context, Facts & Travel Advice
4
Preparedness & Prevention
3
Roadmaps, Action Plans & Policies
2
Assessment & Studies
1
Ebola Prevention & Control
1
Communication & Training
1
Maps
1
Laboratory & Sampling
1
Situation Reports & Updates
1
PLoS Negl Trop Dis 11(2): e0005356 -Published: February 23, 2017 21 pp
This report describes the work done by WHO from January 2015 up to the end of December 2016 to address the long-term issues of survivor care, health-systems strengthening and research.
The Committee examined the clinical development of Ebola virus vaccines and conducted an inventory of available data on their safety. It also reviewed 3 generic issues: updating a global strategy on vaccine safety, use of a network of distributed data ...
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...
An example of integration of research into epidemic response.
New England Journal of Medicine 374:1,pp23-32
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 11, November 2017
The Lancet Global Health 2016 Published Online August 30, 2016
http://dx.doi.org/10.1016/S2214-109X(16)30175-9
Researchers are devising a clinical-trial protocol to test three medicines in Africa's latest outbreak
Nature doi: 10.1038/d41586-018-06132-7
Eurosurveillance. Vol. 23 (2018) Issue 9 (10 May 2018)
The Ministry of Health is working with WHO, Gavi, MSF, UNICEF and other partners to ring vaccinate high-risk populations in Ebola-affected health zones in the Democratic Republic of the Congo. As vaccine supplies arrive in Geneva ahead of deployment to Kinshasa, WHO’s Dr Peter Salama explains what...
